Webinar

Webinar WEBINAR: Outsourcing Analytical Testing for Biologics from a CRO point of view!
8.31.2017

WEBINAR: Outsourcing Analytical Testing for Biologics from a CRO point of view!

Biologics are large molecules with inherently complex structural heterogeneity. Thus, the analytical tests to support CMC (Chemical, Manufacturing and Controls) activities of biologics need to be highly sophisticated to reveal the multifaceted quality attributes. As biopharmaceutical companies are increasingly outsourcing analytical testing to CROs (contract research organizations), the paradigm has shifted for CROs from merely being a pair of extra testing hands to problem-solvers. The new trend is driving CROs to hire top-tier scientists to provide expert solutions for clients with in-depth characterization of the quality attributes. This analysis is performed using cutting edge technologies for structural elucidation, post-translation modification, and degradation pathways, etc. In the meantime, the modalities of biologics are becoming more and more complex, such as antibody drug conjugates, PEGylated proteins, conjugate vaccines, fusion proteins, and gene and cell based therapies. In light of this complexity, biopharmaceutical and biotech companies are demanding innovative and creative solutions from CROs.

The advent of revolutionary technologies offers new instruments to advance analytical science. Many analytical methods are rapidly evolving. For example, high-resolution mass spectrometry enables top-down, or middle-down approaches to characterize structure and modification of the macromolecules, in addition to traditional bottom-up peptide mapping; the workflow for N-linked glycan analysis is integrated with highly active PNGase F and a novel probe for both fluorescence and mass detection, while new endoglycosidase for O-linked glycan is becoming commercially available; capillary electrophoresis is replacing traditional slab gel for SDS-PAGE, IEF and Western blotting. Advances in instrumentation for surface plasmon resonance (SPR) and bio-layer interferometry (BLI) techniques make it feasible for routine testing of receptor binding kinetics. In addition, the Solo VPE technologyenables direct and neat determination of protein concentration without the need for sample dilution and thus received rapid acceptance in the biopharmaceutical industry when it was introduced.

At the center of the field, regulatory agencies have provided specific guidelines for large molecule analytical testing. In the "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use" document, the US Food and Drug Administration (FDA) requires that "a precise and thorough characterization of antibody structural integrity, specificity, and potency should be conducted and described in the IND." While the guidance pertained specifically to monoclonal antibody products for human use, it can be applied to all other biologics in general. In July 2017, FDA issued the guidance for "Analytical Procedures and Methods Validation for Drugs and Biologics", which complements the International Conference on Harmonisation (ICH) guidance Q2(R1), "Validation of Analytical Procedures: Text and Methodology Q2(R1)" for developing and validating analytical methods. The guidance provided general requirements for analytical procedure development and validation using statistical tools, for example, analysis of variance (ANOVA) to assess regression analysis.

In response to the demand from biopharmaceutical and biotech companies, as well as the regulatory agencies, CROs also need to modernize the analytical capabilities to support clients and solve the most challenging problems for large molecules, as well as provide service for release and stability testing. This webinar will provide the audience with a general explanation of how CROs can support biologics testing, ranging from product release and stability to in-depth structural elucidation and degradation pathway studies.

Click here for More Information: http://xtalks.com/Outsourcing-Analytical-Testing-Biologics-CRO.html
Click here to REGISTER: https://register.gotowebinar.com/register/1041119148838122243
See Event Info
Webinar WEBINAR: Pre-existing antibodies within clinical samples: How does this affect immunogenicity outcomes?
10.19.2017

WEBINAR: Pre-existing antibodies within clinical samples: How does this affect immunogenicity outcomes?

Pre-existing antibodies in treatment-naïve subjects have been often detected during clinical ADA assessments. However, limited information on prevalence, physiological effect, and impact on post-treatment ADA induction is available. This presentation will address pre-existing antibody characterization and implications for immunogenicity management and strategies during clinical studies.

See Event Info
3.26.2018

WEBINAR: Bioanalysis of Liposomal Drugs by LC-MS/MS

This webinar discusses the development and validation of LC-MS/MS method for the quantitation of liposomal drugs.
See Event Info
10.18.2018

WEBINAR: Incorporation of Microsampling Techniques in Bioanalytical Assays – Dried Blood Spots (DBS) and capillary microsampling

This webinar talks about the benefit of incorporating the microsampling technique in bioanlaytical assays, as well as the effort to overcome the challenges.
See Event Info
10.30.2018

WEBINAR: Strategies and Solutions for Early Phase Formulation Development and CTM Manufacturing

This webinar explores the tools and approaches available for overcoming common yet frustrating challenges in your formulation development.
See Event Info
Webinar Chinese American Chromatography Association (CACA) Webinar by Dr. Kai Wang
1.30.2019

Chinese American Chromatography Association (CACA) Webinar by Dr. Kai Wang

Join Dr. Kai Wang, Lab Manager of Bioanalytical Services with Frontage Laboratories, for his webinar on Bioanalysis of Lipsome Drugs by LC-MS/MS
See Event Info
Webinar Webinar: Stability Testing as a Quality Control Measure: Optimizing the Process throughout the Product Lifecycle
6.25.2019

Webinar: Stability Testing as a Quality Control Measure: Optimizing the Process throughout the Product Lifecycle

See Event Info
Featured ADC Webinar – “Bioanalytical Strategies for PK Analysis of Antibody–Drug Conjugate (ADC) Therapeutics using LC–HRMS and LC–MS/MS”
9.24.2019

ADC Webinar – “Bioanalytical Strategies for PK Analysis of Antibody–Drug Conjugate (ADC) Therapeutics using LC–HRMS and LC–MS/MS”

Join our Webinar entitled, "Bioanalytical Strategies for PK Analysis of Antibody–Drug Conjugate (ADC) Therapeutics using LC–HRMS and LC–MS/MS'
See Event Info